- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Eris Lifesciences Limited — Board Meeting, 20-03-2026: Outcome of Board Meeting
20-03-2026 | 03:29 pm
20-03-2026 | 03:29 pm
Eris Lifesciences' board approved acquiring Velbiom Probiotics' branded probiotic products business for INR 50 Cr via a slump sale. This move strengthens Eris's portfolio in metabolic health, gut wellness, and women's health, with the acquired business posting Rs 16.02 Cr revenue in 9M FY26.
No comments yet. Be the first to comment!